Radiation Safety Angiosystems partners with ORSIF to address occupational radiation exposure, presenting an opportunity to cross-sell and co-market SorbX scatter radiation protection shields to hospitals, radiology centers, and interventional suites.

Mid-market Scale With 11-50 employees and revenue in the $25M–$50M range, Angiosystems sits in a mid-market segment ripe for expansion through channel partnerships, distributors, and OEM collaborations with larger suppliers in the medical device ecosystem.

Surgical Imaging Focus The company’s emphasis on interventional fluoroscopy radiation safety suggests upsell potential for related imaging hardware, protective apparel, shielding solutions, and integrated workflow optimization tools for cath labs and ORs.

Digital Toolkit Adoption of WordPress, Shopify, and Microsoft 365 indicates a readiness for digital marketing, e-commerce enablement, and cloud-based collaboration—opportunities to offer marketing automation, e-commerce enhancements, and sales enablement platforms.

Competitive Positioning Compared to large incumbents, Angiosystems’ size and niche focus on radiation protection can be leveraged to propose targeted partnerships, refillable consumables, service contracts, and integration with major medical device distributors seeking specialized PPE and shield products.